,,ii #aahth ,,congress #ast ,session ,s4 #bfhc ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #bg1 #bjbc,mr4 ,scott of ,florida introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to establish requirements for purchasing certain generic drugs from manufacturers who produce the drug domestically4 #a4 ,short title ,this ,act may be cited as the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act or the ,,american ,,drugs ,act4 #b4 ,,fda notification 7a7 ,in general ,the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs 7referred to in this section as the ,commissioner71 shall issue notifications to the ,administrator of the ,centers for ,medicare ,medicaid ,services1 the ,secretary of ,defense1 and the ,secretary of ,veterans ,affairs upon a determination by the ,commissioner that-- 7#a7 there are at least #b approved generic drugs that are manufactured domestically1 as described in subsection 7b71 each of which-- 7,a7 is approved pursuant to an application under section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j772 and 7,b7 references the same listed drug under paragraph 7#g7 of such section #eje7;j72 or 7#b7 there are fewer than #b approved generic drugs that are manufactured domestically-- 7,a7 approved pursuant to an application under section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j772 and 7,b7 that reference the same listed drug under paragraph 7#g7 of such section #eje7;j7 as another drug approved under such section #eje7;j72 7#c7 paragraph 7#a77;,b7 may soon apply because the ,commissioner has been notified that a holder of an approved application for a generic drug that is manufactured domestically1 as described in subsection 7b71 plans to discontinue manufacturing1 or expects an interruption of the manufacture of1 such drug at an establishment described in subsection 7b77#a77;,b72 or 7#d7 a generic drug that is manufactured domestically1 as described in subsection 7b71 is in shortage1 as defined in section #ejf;,c7h77#b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cef;c7h77#b774 7b7 ,generic drug manufactured domestically described ,in this section1 a generic drug that is manufactured domestically-- 7#a7 is a drug-- 7,a7 that is approved under section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j772 and 7,b7 for which there is at least one establishment registered under section #eaj7;b77#a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj7;b77#a77 engaged in the manufacture of the finished dosage form of the drug2 and 7#b7 excludes any authorized generic drug1 as defined in section #eje7t77#c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7t77#c774 7c7 ,special rule concerning generic drugs in shortage ,a notification under subsection 7a77#d7 that a generic drug that is manufactured domestically1 as described in subsection 7b71 is in shortage1 shall apply only for-- 7#a7 an initial period of not more than #ij days2 and 7#b7 such additional #cj-;day renewal periods as the ,secretary of ,health and ,human ,services may indicate by-- 7,a7 submitting to ,congress a notification of intent to renew the notification under subsection 7a77#d72 and 7,b7 publicly posting information about the shortage1 the steps the ,food and ,drug ,administration is taking to address the shortage1 and an estimated date by which the shortage is expected to be resolved4 #c4 ,expedited consideration of certain abbreviated new drug applications ,chapter ,v of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cea et seq47 is amended by inserting after section #ejf,l the following3 #ejf,m4 ,expedited consideration of certain abbreviated new drug applications 7a7 ,in general ,the ,secretary may1 at the request of a sponsor of an application for an applicable drug1 expedite the development and review of an abbreviated new drug application under section #eje7;j7 for such drug4 7b7 ,applicable drug ,for purposes of this section1 an applicable drug is a drug for which there are fewer than #b drugs approved under section #eje7;j7 that are manufactured domestically1 as described in paragraph 7#b71 each of which is approved pursuant to an application under section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j77 and references the same listed drug under paragraph 7#g7 of such section #eje7;j74 7c7 ,actions ,in expediting the development and review of an application under subsection 7a71 the ,secretary may1 as requested by the applicant1 take actions including the following3 7#a7 ,hold meetings with the applicant and the review team throughout the development of the drug prior to submission of the application for such drug under section #eje7;j74 7#b7 ,provide timely advice to1 and interactive communication with1 the applicant regarding the development of the drug to ensure that the development program to gather the data necessary for approval is as efficient as practicable4 7#c7 ,involve senior managers and experienced review staff1 as appropriate1 in a collaborative1 coordinated review of such application1 including with respect to drug-device combination products and other complex products4 7#d7 ,assign a cross-disciplinary project lead-- 7,a7 to facilitate an efficient review of the development program and application1 including manufacturing inspections2 and 7,b7 to serve as a scientific liaison between the review team and the applicant4 7d7 ,reporting requirement ,not later than one year after the date of the approval of an application under section #eje7;j7 with respect to a drug for which the development and review is expedited under this section1 the sponsor of such drug shall report to the ,secretary on whether the drug has been marketed in interstate commerce since the date of such approval4 4 #d4 ,prohibition of payment under ,medicare part ,b or coverage under ,medicare part ,d for certain generic drugs manufactured outside of the ,united ,states 7a7 ,medicare part ,b ,section #ahdb7o7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acieu7o77 is amended by adding at the end the following new paragraph3 7#i7 7,a7 ,payment shall only be made under this part for a generic drug furnished on or after ,january #a1 #bjbe1 if it is a generic drug manufactured domestically 7as described in section #b7;b7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act74 7,b7 ,subparagraph 7,a7 shall not apply1 with respect to a drug1 during any period for which the ,secretary-- 7i7 has notified the ,administrator of the ,centers for ,medicare ,medicaid ,services pursuant to section #b7;a7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act that the circumstances under paragraph 7#b71 7#c71 or 7#d7 of such section apply2 or 7ii7 otherwise determines that access to the drug is essential to the health of beneficiaries under this part4 4 7b7 ,medicare part ,d ,section #ahfj;,d-#db of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aeb7 is amended by adding at the end the following new subsection3 7e7 ,prohibition of coverage for certain generic drugs manufactured outside of the ,united ,states 7#a7 ,in general ,coverage shall only be available under this part for a covered part ,d drug that is a generic drug dispensed on or after ,january #a1 #bjbe1 if it is a generic drug manufactured domestically 7as described in section #b7;b7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act74 7#b7 ,exceptions ,paragraph 7#a7 shall not apply1 with respect to a covered part ,d drug1 during any period for which the ,secretary-- 7,a7 has notified the ,administrator of the ,centers for ,medicare ,medicaid ,services pursuant to section #b7;a7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act that the circumstances under paragraph 7#b71 7#c71 or 7#d7 of such section apply2 or 7,b7 otherwise determines that access to the drug is essential to the health of beneficiaries under this part4 4 #e4 ,prohibition of payment under ,medicaid and ,,chip for certain generic drugs manufactured outside of the ,united ,states 7a7 ,medicaid ,title ,,xix of the ,social ,security ,act 7#db ,u4,s4,c4 #acif et seq47 is amended-- 7#a7 in section #aijc7;i77#aj7-- 7,a7 in subparagraph 7,d71 by striking 2 and and inserting a semicolon2 7,b7 in subparagraph 7,e71 by striking 2 or and inserting 2 and2 and 7,c7 by inserting after subparagraph 7,e7 the following new subparagraph3 7,f7 with respect to any amount expended for a covered outpatient drug which the ,state is required to exclude from coverage under section #aibg7;d77#h72 or 2 and 7#b7 in section #aibg7;d71 by adding at the end the following new paragraph3 7#h7 ,restriction on coverage of foreign-made generic drugs 7,a7 ,in general ,beginning ,january #a1 #bjbe1 a ,state shall exclude coverage of a foreign-made generic covered outpatient drug if there is a generic drug that is manufactured domestically 7as described in section #b7;b7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act7 that references the same listed drug under section #eje7;j77#g7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act as the foreign-made generic covered outpatient drug4 7,b7 ,definition of foreign-made generic covered outpatient drug ,for purposes of this paragraph1 the term foreign-made generic covered outpatient drug means a covered outpatient drug that-- 7i7 is approved under section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act2 and 7ii7 is not a generic drug that is manufactured domestically 7as described in section #b7;b7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act74 7,c7 ,exceptions ,subparagraph 7,a7 shall not apply to a foreign-made generic covered outpatient drug during any period for which the ,secretary-- 7i7 has notified the ,administrator of the ,centers for ,medicare ,medicaid ,services pursuant to section #b7;a7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act that the circumstances under paragraph 7#b71 7#c71 or 7#d7 of such section apply with respect to such drug2 or 7ii7 otherwise determines that access to the foreign-made generic covered outpatient drug is essential to the health of individuals enrolled for medical assistance under this title4 7,d7 ,notice to ,states ,the ,secretary shall provide notice to ,states if a foreign-made generic covered outpatient drug is subject to exclusion from coverage under this paragraph4 4 7b7 ,,chip ,section #bajg7;e77#a77,m7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acig;gg7e77#a77,m77 is amended by inserting 7#aj77;,f71 after 7#b714 #f4 ,procurement by ,department of ,veterans ,affairs of generic drugs manufactured domestically 7a7 ,in general ,subchapter ,,ii of chapter #ha of title #ch1 ,united ,states ,code1 is amended by inserting after section #habf the following new section3 #habf;,a4 ,procurement of generic drugs manufactured domestically 7a7 ,in general ,subject to subsection 7b71 the ,secretary may only procure a generic drug if it is a generic drug manufactured domestically1 as described in section #b7;b7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act4 7b7 ,exceptions ,subsection 7a7 shall not apply with respect to a drug during any period for which-- 7#a7 the ,secretary of ,health and ,human ,services has notified the ,secretary of ,veterans ,affairs pursuant to section #b7;a7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act that the circumstances under paragraph 7#b71 7#c71 or 7#d7 of such section apply2 or 7#b7 the ,secretary of ,veterans ,affairs determines that access to the drug is essential to the health of beneficiaries under the laws administered by the ,secretary4 4 7b7 ,clerical amendment ,the table of sections at the beginning of such subchapter is amended by inserting after the item relating to section #habf the following new item3 #habf;,a4 ,procurement of generic drugs manufactured domestically4 4 7c7 ,effective date ,the amendments made by this section shall take effect on ,january #a1 #bjbe4 #g4 ,procurement by ,department of ,defense of generic drugs manufactured domestically 7a7 ,in general ,chapter #ee of title #aj1 ,united ,states ,code1 is amended by inserting after section #ajgd;g the following new section3 #ajgd;g-#a4 ,procurement of generic drugs manufactured domestically 7a7 ,in general ,subject to subsection 7b71 the ,secretary of ,defense may only procure a generic drug if it is a generic drug manufactured domestically1 as described in section #b7;b7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act4 7b7 ,exceptions ,subsection 7a7 shall not apply with respect to a drug during any period for which-- 7#a7 the ,secretary of ,health and ,human ,services has notified the ,secretary of ,defense pursuant to section #b7;a7 of the ,accelerating ,movement of ,essential ,rx ,items to ,create ,access to ,national ,drug ,resources for ,,us ,government ,services ,act that the circumstances under paragraph 7#b71 7#c71 or 7#d7 of such section apply2 or 7#b7 the ,secretary of ,defense determines that access to the drug is essential to the health of beneficiaries under the ,,tricare program4 4 7b7 ,clerical amendment ,the table of sections at the beginning of such chapter is amended by inserting after the item relating to section #ajgd;g the following new item3 #ajgd;g-#a4 ,procurement of generic drugs manufactured domestically4 4 7c7 ,effective date ,the amendments made by this section shall take effect on ,january #a1 #bjbe4